tradingkey.logo

CeriBell Inc

CBLL
11.385USD
+0.065+0.57%
收盘 10/31, 16:00美东报价延迟15分钟
416.69M总市值
亏损市盈率 TTM

CeriBell Inc

11.385
+0.065+0.57%

关于 CeriBell Inc 公司

Ceribell, Inc. 是一家商业阶段的医疗技术公司。该公司专注于改变患有严重神经系统疾病的患者的诊断和管理。该公司开发了 Ceribell 系统,这是一种新型的即时诊断脑电图 (EEG) 平台,专门用于满足急性护理环境中患者未满足的需求。通过将专有、高度便携且可快速部署的硬件与复杂的人工智能 (AI) 驱动算法相结合,Ceribell 系统能够快速诊断和持续监测患有神经系统疾病的患者。即时诊断脑电图能够及早发现和管理疑似癫痫发作患者,促进精准的患者护理和全院效率。其 Clarity AI 算法可实时解释脑电图,提供床边警报并持续监测癫痫持续状态。Ceribell 脑电图门户可让您轻松远程实时查看脑电图,并提供预先注释的脑电图见解。

CeriBell Inc简介

公司代码CBLL
公司名称CeriBell Inc
上市日期Oct 11, 2024
CEOMs. Xingjuan (Jane) Chao, Ph.D.
员工数量281
证券类型Ordinary Share
年结日Oct 11
公司地址360 N. Pastoria Avenue
城市SUNNYVALE
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编94085
电话18004360826
网址https://ceribell.com/
公司代码CBLL
上市日期Oct 11, 2024
CEOMs. Xingjuan (Jane) Chao, Ph.D.

CeriBell Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+0.32%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.10M
-0.26%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
484.18K
--
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
88.68K
-0.77%
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
52.06K
-41.11%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
+103.09%
Ms. Erica J. Rogers
Ms. Erica J. Rogers
Director
Director
--
--
Brian Johnston
Brian Johnston
Investor Relations
Investor Relations
--
--
Joseph Manni
Joseph Manni
Chief Revenue Officer
Chief Revenue Officer
--
--
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+0.32%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.10M
-0.26%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
484.18K
--
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
88.68K
-0.77%
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
52.06K
-41.11%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
+103.09%

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2022
业务USD
名称
营收
占比
EEG recorders and EEG headbands, point in time
15.92M
75.11%
EEG portal and Clarity subscriptions, over time
5.28M
24.89%
暂无数据
业务
地区
业务USD
名称
营收
占比
EEG recorders and EEG headbands, point in time
15.92M
75.11%
EEG portal and Clarity subscriptions, over time
5.28M
24.89%

股东统计

更新时间: 9月8日 周一
更新时间: 9月8日 周一
持股股东
股东类型
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
12.79%
TPG Capital, L.P.
10.82%
Longitude Capital Management Co., LLC
6.75%
Ally Bridge Group (HK) Limited
6.66%
Global Value Investment Portfolio Management Pte. Ltd.
6.46%
其他
56.52%
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
12.79%
TPG Capital, L.P.
10.82%
Longitude Capital Management Co., LLC
6.75%
Ally Bridge Group (HK) Limited
6.66%
Global Value Investment Portfolio Management Pte. Ltd.
6.46%
其他
56.52%
股东类型
持股股东
占比
Investment Advisor
41.55%
Investment Advisor/Hedge Fund
18.75%
Private Equity
10.82%
Individual Investor
10.66%
Venture Capital
9.21%
Hedge Fund
2.82%
Research Firm
0.96%
Pension Fund
0.36%
Bank and Trust
0.20%
其他
4.67%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
179
30.96M
84.45%
+3.45M
2025Q2
162
33.13M
90.36%
+3.75M
2025Q1
157
34.07M
94.45%
+6.99M
2024Q4
111
32.79M
91.42%
+9.94M

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Fidelity Management & Research Company LLC
4.69M
12.79%
-62.59K
-1.32%
Jun 30, 2025
TPG Capital, L.P.
3.97M
10.82%
--
--
Jun 30, 2025
Longitude Capital Management Co., LLC
2.48M
6.75%
+2.48M
--
Oct 16, 2024
Ally Bridge Group (HK) Limited
2.44M
6.66%
+265.06K
+12.18%
Jun 30, 2025
Global Value Investment Portfolio Management Pte. Ltd.
2.37M
6.46%
--
--
Dec 31, 2024
Red Tree Management, LLC
2.21M
6.02%
--
--
Jun 30, 2025
Parvizi (Josef)
2.09M
5.7%
+6.62K
+0.32%
Apr 11, 2025
BlackRock Institutional Trust Company, N.A.
1.37M
3.74%
+587.42K
+75.05%
Jun 30, 2025
The Vanguard Group, Inc.
1.33M
3.61%
+631.24K
+90.98%
Jun 30, 2025
Chao (Xingjuan)
1.10M
3%
-2.89K
-0.26%
Aug 25, 2025
查看更多

持股ETF

更新时间: 10月6日 周一
更新时间: 10月6日 周一
机构名称
占比
iShares Neuroscience and Healthcare ETF
0.52%
Hypatia Women CEO ETF
0.42%
Global X HealthTech ETF
0.28%
Fidelity Fundamental Small-Mid Cap ETF
0.1%
iShares Micro-Cap ETF
0.06%
iShares Russell 2000 Growth ETF
0.02%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
查看更多
iShares Neuroscience and Healthcare ETF
占比0.52%
Hypatia Women CEO ETF
占比0.42%
Global X HealthTech ETF
占比0.28%
Fidelity Fundamental Small-Mid Cap ETF
占比0.1%
iShares Micro-Cap ETF
占比0.06%
iShares Russell 2000 Growth ETF
占比0.02%
ProShares Hedge Replication ETF
占比0.01%
ProShares UltraPro Russell2000
占比0.01%
iShares Russell 2000 ETF
占比0.01%
Proshares Ultra Russell 2000
占比0.01%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
KeyAI